Hyalex Orthopaedics earned FDA 510(k) clearance for its Slalom MTP hemiarthroplasty implant, according to an April 21 news release.
The implant is designed around the proprietary Hydrosurf materials platform and is for the treatment of degenerative conditions affecting the first metatarsophalangeal joint. The Slalom device restores joint function while preserving bone and soft tissue.
Hyalex plans to launch the system in a limited U.S. market release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.